Novartis Ag Adr Stock Technical Analysis

NVS Stock  USD 95.88  0.61  0.64%   
As of the 28th of March, Novartis secures the Downside Deviation of 1.1, mean deviation of 0.7231, and Risk Adjusted Performance of 0.0193. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG ADR, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Novartis, which can be compared to its peers in the industry. Please verify Novartis AG ADR jensen alpha and semi variance to decide if Novartis AG ADR is priced some-what accurately, providing market reflects its recent price of 95.88 per share. Given that Novartis AG ADR has jensen alpha of (0.03), we recommend you to check Novartis's last-minute market performance to make sure the company can sustain itself at a future point.

Novartis Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Novartis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Novartis
  
Novartis' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Novartis Analyst Consensus

Target PriceAdvice# of Analysts
112.75Buy12Odds
Novartis AG ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Novartis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Novartis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Novartis AG ADR, talking to its executives and customers, or listening to Novartis conference calls.
Novartis Analyst Advice Details
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novartis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novartis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Novartis AG ADR Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Novartis AG ADR volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Novartis AG ADR Trend Analysis

Use this graph to draw trend lines for Novartis AG ADR. You can use it to identify possible trend reversals for Novartis as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Novartis price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Novartis Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Novartis AG ADR applied against its price change over selected period. The best fit line has a slop of   0.11  , which may imply that the returns on investment in Novartis AG ADR will continue to fail. It has 122 observation points and a regression sum of squares at 468.44, which is the sum of squared deviations for the predicted Novartis price change compared to its average price change.

About Novartis Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novartis AG ADR on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novartis AG ADR based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novartis AG ADR price pattern first instead of the macroeconomic environment surrounding Novartis AG ADR. By analyzing Novartis's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novartis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novartis specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2024 (projected)
Price Earnings Ratio7.7326.9213.62
Short Term Coverage Ratios2.292.31.51

Novartis March 28, 2024 Technical Indicators

Most technical analysis of Novartis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novartis from various momentum indicators to cycle indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Novartis March 28, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Novartis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Novartis AG ADR is a strong investment it is important to analyze Novartis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novartis' future performance. For an informed investment choice regarding Novartis Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Novartis Stock analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.987
Dividend Share
3.919
Earnings Share
4.1
Revenue Per Share
22.467
Quarterly Revenue Growth
0.074
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.